Business Wars
Wondery
Netflix vs. HBO. Nike vs. Adidas. Business is war. Sometimes the prize is your wallet or your attention. Sometimes, it’s just the fun of beating the other guy. The outcome of these battles shapes what we buy and how we live. Business Wars gives you the unauthorized, real story of what drives these companies and their leaders, innovators, investors and executives to new heights -- or to ruin. Hosted by David Brown, former anchor of Marketplace. From Wondery, the network behind Against the Odds and American History Tellers.Listen to Business Wars on the Wondery App or wherever you get your podcasts. Experience all episodes ad-free and be the first to binge the newest season. Unlock exclusive early access by joining Wondery+ in the Wondery App or on Apple Podcasts. Start your free trial today by visiting wondery.com/links/business-wars/ now.
Episodes
Mentioned books
May 10, 2021 • 23min
Vaccine Wars | Big Pharma's Big Gamble Pays Off | 7
Annalisa Merelli, a healthcare reporter for Quartz, dives into the tumultuous world of COVID-19 vaccines, discussing the monumental risks taken by companies like BioNTech and Moderna. She unpacks the international collaborations that sped up vaccine development and the complex safety concerns around the Johnson & Johnson vaccine. Merelli also addresses the stark disparities in global vaccine distribution, particularly in India, and highlights the transformative potential of mRNA technology in shaping future healthcare.
May 5, 2021 • 32min
Vaccine Wars | Arms Race | 6
In late 2020, a fierce global competition for COVID-19 vaccines heats up as supplies dwindle. Tension rises in South Africa as new variants pose a threat. Johnson & Johnson faces setbacks with a critical contamination issue, while Pfizer rapidly scales up production. A rare blood clot concern leads to a pause in J&J's vaccine rollout, highlighting both the urgency and complexity of the situation. Amid these hurdles, innovators like BioNTech and Moderna emerge as key players, pushing the boundaries of vaccine technology and access.
May 3, 2021 • 28min
Vaccine Wars | Trials and Tribulations | 5
As the first vaccine trial results loom in fall 2020, tensions rise in the pharmaceutical world. AstraZeneca and Johnson & Johnson face unexpected hurdles, while Pfizer shares exciting news about a 95% efficacy rate. Political turmoil impacts public trust and complicates the race for a reliable vaccine. Amid breakthroughs and challenges, the importance of collaboration, particularly between Oxford and AstraZeneca, becomes clear. Meanwhile, vaccination enthusiasm spikes in the U.S. even as other regions struggle with variants.
Apr 28, 2021 • 26min
Vaccine Wars | Warp Speed | 4
In the summer of 2020, the U.S. government launches Operation Warp Speed to accelerate COVID-19 vaccine development. Pfizer confronts unique storage challenges while strategizing production scaling. The podcast dives into the fierce competition between pharmaceutical giants like Pfizer and Moderna, revealing the pressures of congressional scrutiny and ethical considerations in clinical trials. It emphasizes the importance of diversity in trials and the commitment to uphold scientific integrity amidst a politically charged landscape.
Apr 26, 2021 • 28min
Vaccine Wars | Long Shot | 3
In February 2020, the race to develop a COVID-19 vaccine heats up, with Moderna pushing ahead to start human trials. Tension mounts as they prepare their first batch for safe transport amid the pandemic chaos. The podcast dives into the fierce competition among pharmaceutical giants like Pfizer and BioNTech, highlighting their strategic partnerships and the immense pressure to succeed. Listeners discover the intricate decisions facing these key players as they navigate the urgent global health crisis.
Apr 21, 2021 • 28min
Vaccine Wars | The Hype Cycle | 2
Delve into the inspiring journey of a Hungarian biochemist fighting for mRNA research against tremendous odds. Her dedication faces obstacles, including funding challenges and personal crises. Discover the groundbreaking collaboration that paved the way for Moderna's formation. Witness the thrilling highs and lows of the mRNA market amid a global health crisis. As a new coronavirus threatens the world, urgent discussions ignite about developing a vaccine, propelling mRNA technology to the forefront of medicine.
Apr 19, 2021 • 26min
Vaccine Wars | This is Not a Drill | 1
In early January 2020, a mysterious virus erupts in Wuhan, prompting scientists to urgently develop a vaccine. Biotech companies face immense pressure as they race against time amidst a global health crisis. Early responses reveal the complexities of virus identification and the challenges ahead. With the World Health Organization declaring a global emergency, researchers adapt their strategies rapidly, showcasing a fierce competition within the pharmaceutical industry. It's a gripping narrative of innovation, urgency, and the fight for public health.
Apr 14, 2021 • 23min
KFC vs Chick-fil-A | The Fried Chicken Future | 7
Nick Wiger, a comedian and co-host of the Doughboys podcast, dives into the fierce rivalry between KFC and Chick-fil-A. He explores how Chick-fil-A capitalized on the chicken sandwich craze, leaving KFC scrambling to innovate. The conversation touches on the marketing tactics of various fried chicken chains, the emotional nostalgia tied to fast food, and the evolution of consumer preferences amid ethical consumption debates. Wiger also speculates on the future of plant-based options in the fast food landscape.
Apr 13, 2021 • 24min
David Brown on The Art of Business Wars | 7
Join Rufus Griscom, host of The Next Big Idea podcast, as he dives into the creation of 'The Art of Business Wars,' a book that brings together thrilling tales of competition. He and David Brown explore the essence of a great business rivalry, tackling the dramatic clash between Gibson and Fender in the electric guitar arena. They also dissect Apple's strategic evolution under Steve Jobs, highlighting adaptability amid crises. With a sprinkle of humor, they discuss turning challenges into growth opportunities, making it a must-listen for any business enthusiast!
Apr 12, 2021 • 22min
KFC vs Chick-fil-A | Sandwichmania | 6
In the early 2000s, KFC faces protests from PETA, leading to a drop in sales as Chick-fil-A rises with engaging marketing tactics. Controversial remarks from Chick-fil-A’s President spark backlash, yet the brand continues to thrive. Meanwhile, Popeyes reinvents itself under new leadership with a fried chicken sandwich that shakes up the market. The competition escalates into a Twitter feud over sandwich supremacy, culminating in the explosive Chicken Sandwich Wars of 2019. All this unfolds as the industry grapples with a shift toward sustainability.
